As global momentum builds around psychedelic reforms, the United Nations’ Common Position on Drug Policy offers a critical framework for shaping a humane, rights-based approach to this issue on the international stage. This panel will explore how the UN’s focus on public health, human rights, and sustainable development can support decriminalization efforts, while aligning with the goals of the 2030 Agenda for Sustainable Development.
Jorge Valderrábano
Oregon and Colorado have pioneered and iterated on the first state-regulated psychedelics markets. But there are many additional ways beyond the Oregon and Colorado models to establish a market.
Leonard Gilroy, Barine Majewska, Courtney Barnes, Jared Moffat, Allison Hoots
Integration of psychedelic therapy into healthcare requires clinics to provide safe care. Planning infrastructure carefully, considering environmental factors, is crucial for successful delivery of psychedelic services.
Daniel Kelly, Gregory Kearns, Payton Nyquvest
Psychedelic businesses have rapidly emerged on American and Canadian exchanges, creating a multibillion dollar market. Industry insiders discuss challenges and predictions for psychedelic public companies.
Patrick Trucchio, Florian Brand, George Tziras, Tim Chang
Panel: New psychedelic entrepreneurs discuss unique business structures and financial strategies aligning with values and purpose, rejecting traditional models for innovative, purpose-driven for-profit ventures.
Daniel Tarockoff, Scarlet Masius
Dr. Bennett explores the expanding field of ketamine treatment, covering current trends, controversies, and potential topics like enantiomers, mail order platforms, provider training, economics, and FDA approval challenges.
Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use. Leaders discuss challenges and lessons learned in implementation.
Rev Veronica Lightning Horse P…, Ean Seeb, Hadas Alterman
Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.
Angela E Albee, Sam Chapman
Commander Gunn, a USPHS officer and FDA Investigator, specializes in international inspections of drug, biologic, and device trial sponsors and study sites. With 13 years of experience, he previously held
Commander Gene Gunn
Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.
Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.